Pulp regeneration compositions and methods of forming and using the same
US-11504303-B2 · Nov 22, 2022 · US
US12016938B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12016938-B2 |
| Application number | US-202217969990-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 20, 2022 |
| Priority date | Dec 1, 2016 |
| Publication date | Jun 25, 2024 |
| Grant date | Jun 25, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A dental tissue regenerative composition. The composition includes a combination of (1) human dental pulp stem cells and (2) at least one of human umbilical vein endothelial cells or vascular endothelial growth factor. The combination is encapsulated in a light-activated gelatin methacrylate hydrogel.
Opening claim text (preview).
What is claimed is: 1. A three-dimensional biomimetic model comprising: a tissue regenerative composition comprising a material at least partly obtained from an extracted tooth, and a light-activated hydrogel encapsulating the material; a biomimetic enamel organ layer, and a biomimetic pulp organ. 2. The three-dimensional biomimetic model of claim 1 , wherein the tissue regenerative composition a photo-initiator. 3. The three-dimensional biometric model of claim 2 , wherein the photo-initiator is present at a concentration of about 0.05% to about 0.5% (w/v). 4. The three-dimensional biometric model of claim 2 , wherein the photo-initiator is selected from the group consisting of: 1-[4-(2-hydroxy ethoxy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one, azobisisobutyronitrile, benzoyl peroxide, di-tert-butyl peroxide, 2,2-dimethoxy-2-phenylacetophenone, Eosin Y, and any combination thereof. 5. The three-dimensional biometric model of claim 1 , wherein the hydrogel is a gelatin methacrylate hydrogel. 6. The three-dimensional biometric model of claim 5 , wherein the gelatin methacrylate hydrogel is present at a concentration of about 3% to about 5% (w/v). 7. The three-dimensional biometric model of claim 1 , wherein the material obtained from the extracted tooth includes dental pulp stem cells. 8. The three-dimensional biometric model of claim 7 , wherein the material further includes at least one of umbilical vein endothelial cells or vascular endothelial growth factor. 9. The three-dimensional biometric model of claim 7 , wherein the dental pulp stem cells have been isolated from dental pulp. 10. The three-dimensional biometric model of claim 9 , wherein the dental pulp is from a mature tooth. 11. A method of forming a three-dimensional biometric model, the method comprising: forming a biomimetic enamel organ layer from a first material at least partly obtained from an extracted tooth, the first material being encapsulated in a light-activated hydrogel; and forming a biomimetic pulp organ from a second material at least partly obtained from an extracted tooth, the second material being encapsulated in the light-activated hydrogel. 12. The method of claim 11 , wherein the hydrogel is a gelatin methacrylate hydrogel. 13. The method of claim 12 , wherein the gelatin methacrylate hydrogel is present at a concentration of about 3% to about 5% (w/v). 14. The method of claim 11 , wherein at least one of the first and second materials obtained from the extracted tooth includes dental pulp stem cells. 15. The method of claim 14 , wherein at least one of the first and second materials further comprises at least one of umbilical vein endothelial cells or vascular endothelial growth factor. 16. The method of claim 14 , wherein the dental pulp stem cells have been isolated from dental pulp. 17. The method of claim 16 , wherein the dental pulp is from a mature tooth. 18. The three-dimensional biomimetic model of claim 1 , wherein the biomimetic enamel organ layer includes epithelial cells. 19. The three-dimensional biomimetic model of claim 1 , wherein the biomimetic pulp organ includes mesenchymal cells. 20. The method of claim 11 , wherein the first material includes epithelial cells. 21. The method of claim 11 , wherein the second material includes mesenchymal cells.
Apical treatment · CPC title
Implements for surgical treatment of the roots or nerves of the teeth; Nerve needles; Methods or instruments for medication of the roots · CPC title
Medicaments · CPC title
Photochemical radical initiators · CPC title
for dental implants or prostheses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.